Sharlene Gill: Very informative and impressive compilation
Sharlene Gill shared on X/Twitter:
“Toni Choueiri – very informative and impressive compilation: exciting to see the progress made in cancer treatment in 2023.
Wearing my GI cancer hat. 100 percent agree with
- SUNLIGHT and CODEBREAK300
- KN811
- FOENIX-CCA
Would add shout-outs to
- PROSPECT – selective RT in rectal CA NEJM
- CABINET – cabozantinib increased PFS in pre-treated NET ESMO23
Alliance for Clinical Trials in Oncology - HE.1 – palliative RT of sx HCC/liver mets less pain
CCTG - SPOTLIGHT – zolbetuximab increased OS in CLDN18.2+ GC.“
Visit Toni Choueiri’s post.
Source: Sharlene Gill/X
Dr. Sharlene Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver, Canada. Dr. Gill serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee and Chair of the UBC Department of Medicine Mentoring Committee.
She is the Editor-in-Chief for Current Oncology and is the President of the Canadian Association of Medical Oncologists. Her TEDx talk in 2022 on ‘How to Flip the Script on Cancer’ delivered her passion for patient advocacy and empowerment.